Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 18, 2019
There is value in treating elevated levels of diabetes distress: the clinical impact of targeted interventions in adults with Type 1 diabetes
D Hessler, L Fisher, W Polonsky, et al.
Neuroimage
|
August 1, 1992
Programs for visualization in three-dimensional microscopy
D Hessler, S J Young, B O Carragher, et al.
Heliyon
|
April 3, 2023
Validation of the type 1 diabetes distress scale (T1-DDS) in a large Danish cohort: Content validation and psychometric properties
L E Joensen, P Lindgreen, K Olesen, et al.
Blood
|
June 25, 2010
Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells
Erin Hertlein, Georgia Triantafillou, Ellen J Sass, et al.
Blood
|
July 27, 2013
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
Jason A Dubovsky, Kyle A Beckwith, Gayathri Natarajan, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 18, 2019
There is value in treating elevated levels of diabetes distress: the clinical impact of targeted interventions in adults with Type 1 diabetes
D Hessler, L Fisher, W Polonsky, et al.
Neuroimage
|
August 1, 1992
Programs for visualization in three-dimensional microscopy
D Hessler, S J Young, B O Carragher, et al.
Heliyon
|
April 3, 2023
Validation of the type 1 diabetes distress scale (T1-DDS) in a large Danish cohort: Content validation and psychometric properties
L E Joensen, P Lindgreen, K Olesen, et al.
Blood
|
June 25, 2010
Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells
Erin Hertlein, Georgia Triantafillou, Ellen J Sass, et al.
Blood
|
July 27, 2013
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
Jason A Dubovsky, Kyle A Beckwith, Gayathri Natarajan, et al.
Page
of 3